(b) Univaried description of adherence and independent continuous variables. Adherence is defined as taking more than 80% of medication
| Continuous variables | Age (yrs) of adherent patients | Age (yrs) of nonadherent patients | Number of clinic visits per year of adherent patients | Number of clinic visits per year of nonadherent patients | Duration of disease (yrs) of those adherence | Duration of disease (yrs) of those nonadherent |
|---|---|---|---|---|---|---|
| Immunomodulators | ||||||
| n observations | 91 | 69 | 91 | 69 | 91 | 69 |
| Median | 11.9 | 11.5 | 3 | 2 | 2.3 | 3.64 |
| IQR | 9.06 to 13.80 | 8.80 to 13.32 | 1.00 to 4.00 | 1.00 to 4.00 | 1.90 to 4.35 | 1.30 to 7.25 |
| Mean | 10.95 | 10.59 | 2.88 | 2.79 | 2.88 | 2.8 |
| std. Dev. | 3.79 | 4.07 | 2.11 | 1.91 | 2.11 | 1.91 |
| 5-ASA | ||||||
| n observations | 37 | 35 | 37 | 35 | 37 | 35 |
| Median | 13.18 | 10.99 | 2 | 2 | 2.4 | 2.92 |
| IQR | 7.47, 14.45 | 6.88, 13.18 | 1.00 to 3.00 | 1.00 to 4.00 | 2.00 to 3.25 | 1.88 to 4.43 |
| Mean | 11.12 | 10.46 | 2.7 | 2.69 | 3.26 | 3.63 |
| std. Dev. | 4.87 | 3.74 | 2.25 | 2.21 | 2.25 | 2.6 |
| Biologics | ||||||
| n observations | 65 | 15 | 65 | 15 | 65 | 15 |
| Median | 11.20 | 11.19 | 2.00 | 3.00 | 3.76 | 5.52 |
| IQR | 6.75 to 13.37 | 9.45 to 13.05 | 1.00 to 4.00 | 2.00 to 4.00 | 2.05 to 6.80 | 2.30 to 6.04 |
| Mean | 10.29 | 11.02 | 2.9 | 2.8 | 4.77 | 4.62 |
| std. Dev. | 4.14 | 2.48 | 2.06 | 1.47 | 3.26 | 1.98 |
| Blood work | ||||||
| n observations | 102 | 148 | 102 | 148 | 102 | 148 |
| Median | 12.27 | 10.7 | 2.5 | 2 | 2.73 | 3.7 |
| IQR | 8.36 to 13.73 | 7.10 to 13.05 | 2.00 to 4.00 | 1.00 to 3.00 | 1.90 to 4.51 | 2.2 to 6.80 |
| Mean | 11.12 | 9.84 | 2.9 | 2.21 | 3.45 | 4.71 |
| std. Dev. | 3.9 | 4.01 | 1.89 | 1.82 | 2.33 | 3.03 |